# Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

> **NCT02910284** · — · COMPLETED · sponsor: **Genocea Biosciences, Inc.** · enrollment: 140 (actual)

## Conditions studied

- Genital Herpes Simplex Type 2

## Interventions

- **BIOLOGICAL:** Observational

## Key facts

- **NCT ID:** NCT02910284
- **Lead sponsor:** Genocea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-16
- **Primary completion:** 2017-07-14
- **Final completion:** 2017-07-14
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910284, "Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02910284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*